ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2419

CDK6 Transcripts Expression Control By The Synoviocyte Proliferation Gene, SPACIA1

Rie Komatsu1, Ryoji Fujii1, Tomoo Sato1, Yoshihisa Yamano1, Kazuo Yudoh2, Moroe Beppu3, Kusuki Nishioka4 and Toshihiro Nakajima3,4,5, 1Institute of Medical Science, St. Marianna University School of Medicine, Kanagawa, Japan, 2Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan, 3St. Marianna University School of Medicine, Kanagawa, Japan, 4Tokyo Medical University, Tokyo, Japan, 5Misato Marine Hospital, Kohchi, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Synovitis

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis: Human Etiology and Pathogenesis II

Session Type: Abstract Submissions (ACR)

Background/Purpose: SPACIA1 is a novel gene associated with abnormal synovial proliferation. We have already shown that SPACIA1 could be involved in the progression of synovitis in vivo. We previously reported that SPACIA1 siRNA inhibited the proliferation of rheumatoid arthritis synovial fibroblasts (RASFs) and delayed the cell cycle at the G1 phase. These findings indicate that SPACIA1 is tightly linked to functional genes at the G1 phase; however, the molecular mechanism is still unclear. In particular, CDK6 was found by transcriptome analysis to be downregulated in RASFs that were transfected with SPACIA1 siRNA (Fig. 1.). In the present study we investigated the mechanisms involved in the SPACIA1-related regulation of CDK6 gene expression in vitro.

Methods : RASFs were transfected with control siRNA or SPACIA1 siRNA. Seventy-two hours after transfection, we examined the expression of several key regulators of G1 phase mRNA and protein production by qRT-PCR and Western blot analysis, respectively. To determine the processes responsible for SPACIA1 down-regulation of CDK6 expression, the basal luciferase activity of pGV-basic2 luciferase reporter containing the CDK6 5′-upstream region was analyzed by luciferase assay in cells treated with control siRNA or SPACIA1 siRNA. To determine whether the stability of CDK6 mRNA is regulated by SPACIA1, we compared mRNA decay rates of CDK6 transcripts analyzed by qRT-PCR at different time points following control/SPACIA1 siRNA- and actinomycin D (Act-D)-treatment.

Results : Among the key regulators of the G1 phase, the only gene to be significantly reduced by SPACIA1 siRNA was CDK6, which was reduced to half of its control expression. The basal luciferase activity of the reporter containing the Cdk6 5′-upstream region averaged 8 to 10-fold higher activity than the promoter-less pGV-basic2 luciferase vector. The Cdk6 5′-upstream region could function as a promoter, however, CDK6 promoter activity was not affected by SPACIA1 knockdown. Knockdown of SPACIA1 accelerated the degradation of CDK6 mRNA in the presence of Act-D relative to control siRNA. After 60min of Act-D treatment, 40% of CDK6 mRNA was reduced by SPACIA1 siRNA, but, not control siRNA. This indicates that SPACIA1 is involved in regulation of CDK6 mRNA decay.

Conclusion: We identified that SPACIA1 regulates the functional gene, CDK6, at the G1 phase, and found that the presence of SPACIA1 is due to alterations in CDK6 mRNA turnover.


Disclosure:

R. Komatsu,
None;

R. Fujii,
None;

T. Sato,
None;

Y. Yamano,
None;

K. Yudoh,
None;

M. Beppu,
None;

K. Nishioka,
None;

T. Nakajima,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cdk6-transcripts-expression-control-by-the-synoviocyte-proliferation-gene-spacia1/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology